Greedy Insider
Medicus Pharma Ltd. (MDCX) Insider Trades and Scores
Medicus Pharma Ltd. (MDCX) insider trades: since Sep 4, 2026, Greedy Insider recorded 5 open-market buys and 0 sales on Form 4 from 5 insiders. The strongest recent filing scored 81 (Strong).
Who bought and who sold
Across the last 5 scoreable Form 4 transactions in MDCX, 5 were open-market purchases and 0 were sales. The table lists the most recent filings with each one's Greediness Score, so the structurally unusual trades are easy to spot first.
| Insider | Role | Type | Shares | Date | Score | ||
|---|---|---|---|---|---|---|---|
| Smith Andrew Alasdair | COO | Buy | 735294.0 | 125367.625 | 2026-09-04 | 81 | View |
| Mehmud Faisal | Chief Medical Officer | Buy | 1470588.0 | 250735.25 | 2026-09-04 | 81 | View |
| Brennan Edward J. | Chief Scientific Officer | Buy | 588235.0 | 100294.07 | 2026-09-04 | 81 | View |
| Bonner Carolyn F. | President | Buy | 1470588.0 | 250735.25 | 2026-09-04 | 81 | View |
| Bokhari Raza | CEO | Buy | 2941176.0 | 501470.5 | 2026-09-04 | 81 | View |
The strongest recent filing
Smith Andrew Alasdair (COO) bought 735,294 shares of Medicus Pharma Ltd. on Sep 4, 2026, a filing that scored 81 (Strong). It scored Strong because a senior insider was trading and it was direct personal ownership. The score describes the filing, not future returns. This is not investment advice.
Cluster activity
A cluster buy is present: 5 insiders (Smith Andrew Alasdair, Mehmud Faisal, Brennan Edward J., Bonner Carolyn F.) traded MDCX the same direction within a 7-day window. Shared conviction is a stronger structural signal than a lone trade.
How this compares with Medicus Pharma Ltd.'s own history
Open-market buys make up 100% of the 5 scoreable MDCX transactions on record between Sep 4, 2026 and Sep 4, 2026. Comparing a filing with the company's own buy/sell mix is how you tell a routine disposal from an unusual accumulation.
Methodology and sources
Scores come from six published, user-adjustable factors (insider role, cluster activity, trade size versus the insider's own history, position impact, filing urgency, and direct versus indirect ownership). The score describes the filing, not future returns. This is not investment advice.
Key facts
- Scoreable Form 4 transactions on record: 5
- Open-market buys: 5
- Sales: 0
- Distinct insiders: 5
- Strongest recent Greediness Score: 81 (Strong)
Primary sources
Related
- Strongest filing
- MDCX in the live feed
- How the Greediness Score works
- What is a cluster buy?
- Form 4 transaction codes
The score describes the filing, not future returns. This is not investment advice.